BRIEF published on 03/25/2024 at 07:05, 2 years 2 months ago SYNLAB Reports Solid Financial Performance for FY 2023 Amidst Challenges Financial Performance M&A Activities Organic Growth Annual Results SYNLAB AG
PRESS RELEASE published on 03/25/2024 at 07:00, 2 years 2 months ago SYNLAB delivers robust performance in FY 2023 SYNLAB AG reports robust financial performance in 2023 with revenue of €2.64 billion, driven by 6.4% organic growth and adjusted EBITDA margin of 16.6%. Read the full press release for details Financial Performance Adjusted EBITDA Margin Organic Growth FY 2023 Results SYNLAB AG
PRESS RELEASE published on 11/08/2023 at 07:30, 2 years 7 months ago Continued strong performance in the third quarter of 2023
PRESS RELEASE published on 11/02/2023 at 17:46, 2 years 7 months ago SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
PRESS RELEASE published on 10/10/2023 at 08:32, 2 years 8 months ago SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
PRESS RELEASE published on 09/29/2023 at 08:22, 2 years 8 months ago SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
PRESS RELEASE published on 09/29/2023 at 08:17, 2 years 8 months ago EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
PRESS RELEASE published on 09/29/2023 at 08:09, 2 years 8 months ago EQS-WpÜG: Tender Offer / Target company: SYNLAB AG; Bidder: Ephios Luxembourg S.à r.l.
PRESS RELEASE published on 09/27/2023 at 14:00, 2 years 8 months ago GaN Systems Introduces 4th Generation GaN Power Platform - Raising the Bar for Efficiency and Fueling Accelerated Global Adoption of GaN
PRESS RELEASE published on 08/14/2023 at 07:45, 2 years 10 months ago SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars
Published on 06/20/2026 at 01:00, 1 day 2 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 3 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 22 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 2 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 2 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 5 hours 59 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 21 hours 24 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 7 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 8 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 7 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 8 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 9 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 9 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 9 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
